Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension

This randomized clinical trial assesses the effect of 5 dosages of lorundrostat treatment vs placebo on 8-week systolic blood pressure change among adults with

Related Keywords

United States ,Massachusetts ,Boston ,American ,Catalys Pacific ,Stevene Nissen ,Novo Nordisk ,Group Information ,Gordy Health ,Bristol Myers Squibb ,Astrazeneca ,Lucidact Health ,Clinical Research ,Boehringer Ingelheim ,Mitsubishi ,Novartis ,Tanabe Pharmaceuticals ,Medtronic ,American Heart Association Hypertension Scientific Sessions ,Johnson ,Institute Inc ,Amgen ,Amsterdam Pharmaceuticals ,Cleveland Clinic Coordinating Center ,Between July ,Patients With Uncontrolled Hypertension ,Bend Points ,Size Calculation ,African American ,End Point ,Exploratory End Points ,Biomarker End Points ,Mitsubishi Tanabe Pharmaceuticals ,Cleveland Clinic ,Drs Laffin ,Interest Disclosures ,Crispr Therapeutics ,Mineralys Therapeutics ,Esperion Therapeutics ,New Amsterdam Pharmaceuticals ,